About this videoMedical investigations and experimental projects have enabled scientists in many countries to obtain greater and improved data on diseases previously unknown to the medical community; that is the case of amyotrophic lateral sclerosis (ALS). In this conference, Richard A. Smith, a specialist in this topic, shares some of the main characteristics of this medical condition and describes possible treatments, as well. He explains its pathological traits and course in the human body through time. Afterwards, he describes how several trial and research experiments, performed by him in different institutions applying different techniques and approaches, have offered the possibility for more treatments. Smith explains how ALS influences behavior in patients and how this neural discovery has led to the opportunity of designing an efficient treatment that can extend the patients quality of life. Finally, he recommends clinicians to always be aware of signs shown by the patients which might help the diagnosis and treatment. |
Richard A. Smith is the medical director of the Center for Neurologic Study (CNS), principal researcher at Coordinated Clinical Research, and member of the honorary medical staff at Scripps Memorial Hospital in La Jolla, California. He is also a consultant for Isis Pharmaceutical Corporation and Eli Lily. Dr. Smith has published numerous studies in medical and scientific journals and is the editor of two books, Interferon Treatment of Neurologic Disorders and Handbook of Amyotrophic Lateral Sclerosis. Smith holds a BS from Brandeis University and a MD from University of Miami.
Source: www.cnsonline.org |
CreditsA Survey on Degenerative Diseases of the Central Nervous Systems | |
A Survey on Degenerative Diseases of the Central Nervous System
New Media is Loading... ..Richard A. Smith March 23, 2010 | Universidad Francisco Marroquín | Duración:..
|
||||
Comentarios
Selección del editor
No hay comentarios en esta sección.
No hay comentarios en esta sección.


..












































1


